Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akerley

Showing results (151-160 of 227) with videos related to

Pageof 23
Sort By:
Journal of Thoracic Disease|March 31, 2018
A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapyMatthew A Gubens, Jody C Chuang, Wallace Akerley, et al.
Infection and Immunity|September 20, 2021
Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic AcidJorge E Vidal, Meagan N Wier, Uriel A Angulo-Zamudio, et al.
International Journal of Cancer|March 14, 2023
A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancerLisa A Cannon-Albright, Craig C Teerlink, Jeff Stevens, et al.
BMC Primary Care|October 3, 2023
Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative studyRachel D McCarty, Mollie E Barnard, Katherine A Lawson-Michod, et al.
Journal of the National Cancer Institute|February 21, 2002
Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group BA William Blackstock, James E Herndon, Electra D Paskett, et al.
Cancer|May 7, 2003
Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group BWallace Akerley, James E Herndon, Merrill J Egorin, et al.
Molecular Cancer Therapeutics|December 17, 2010
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancerApostolia-Maria Tsimberidou, Wallace Akerley, Matthias C Schabel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I studyH Safran, T P King, H Choy, et al.
Journal of Neuro-Oncology|July 1, 2024
Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation eraKyril L Cole, Emma R Earl, Matthew C Findlay, et al.
The Oncologist|August 25, 2018
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung CancerConsuelo Buttigliero, Frances A Shepherd, Fabrice Barlesi, et al.
Pageof 23

Showing results (151-160 of 227) with videos related to

Sort By:
Pageof 23
Journal of Thoracic Disease|March 31, 2018
A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapyMatthew A Gubens, Jody C Chuang, Wallace Akerley, et al.
Infection and Immunity|September 20, 2021
Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic AcidJorge E Vidal, Meagan N Wier, Uriel A Angulo-Zamudio, et al.
International Journal of Cancer|March 14, 2023
A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancerLisa A Cannon-Albright, Craig C Teerlink, Jeff Stevens, et al.
BMC Primary Care|October 3, 2023
Pathways to lung cancer diagnosis among individuals who did not receive lung cancer screening: a qualitative studyRachel D McCarty, Mollie E Barnard, Katherine A Lawson-Michod, et al.
Journal of the National Cancer Institute|February 21, 2002
Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group BA William Blackstock, James E Herndon, Electra D Paskett, et al.
Cancer|May 7, 2003
Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group BWallace Akerley, James E Herndon, Merrill J Egorin, et al.
Molecular Cancer Therapeutics|December 17, 2010
Phase I clinical trial of MPC-6827 (Azixa), a microtubule destabilizing agent, in patients with advanced cancerApostolia-Maria Tsimberidou, Wallace Akerley, Matthias C Schabel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I studyH Safran, T P King, H Choy, et al.
Journal of Neuro-Oncology|July 1, 2024
Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation eraKyril L Cole, Emma R Earl, Matthew C Findlay, et al.
The Oncologist|August 25, 2018
Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung CancerConsuelo Buttigliero, Frances A Shepherd, Fabrice Barlesi, et al.
Pageof 23